SCYX-6759
SCYX-6759 is an orally active, blood-brain barrier permeable anti-T. brucei agent. SCYX-6759 inhibits cytochrome P450 (IC50s: 30.3, 30.6, 47.4 μM for 2D6, 2C9, 2C19, respectively.) SCYX-6759 exhibits potent activity against T. b. brucei 427, T. b. rhodesiense STIB900, and T. b. gambiense STIB930, with IC50s of 0.07, 0.038 and 0.030 μg/mL, respectively[1].
Product Specifications
CAS Number
1222509-12-7
UNSPSC
12352005
Target
Cytochrome P450; Parasite
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Field of Research
Infection
Smiles
O=C(C1=CC=C(C=C1C(F)(F)F)F)NC2=CC=C3C(B(OC3)O)=C2
Molecular Formula
C15H10BF4NO3
Molecular Weight
339.05
References & Citations
[1]Nare B, et al. Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis. Antimicrob Agents Chemother. 2010 Oct;54 (10) :4379-88.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472313-500 1x 500 µL
Rb1 (Tumor Suppressor Protein) (RB1/2313R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740010-100 1x 100 µL
MART-1 / Melan-A (M2-9E3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details